Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
6,017,848
Value
$2.98B
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of VRTX by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,017,848$2.98B0.2%−121,773−2.0%ReducedHolders
Q1 20266,139,621$2.73B0.2%+157,716+2.6%AddedHolders
Q4 20255,981,905$2.70B0.2%+8,160+0.1%AddedHolders
Q3 20255,973,745$2.33B0.1%+44,998+0.8%AddedHolders
Q2 20255,928,747$2.63B0.2%+166,987+2.9%AddedHolders
Q1 20255,761,760$2.78B0.2%+113,524+2.0%AddedHolders
Q4 20245,648,236$2.27B0.2%−287,652−4.8%ReducedHolders
Q3 20245,935,888$2.75B0.2%−389,420−6.2%ReducedHolders
Q2 20246,325,308$2.96B0.3%+512,272+8.8%AddedHolders
Q1 20245,813,036$2.42B0.2%+139,617+2.5%AddedHolders
Q4 20235,673,419$2.30B0.2%+77,445+1.4%AddedHolders
Q3 20235,595,974$1.94B0.2%+51,113+0.9%AddedHolders
Q2 20235,544,861$1.95B0.2%+135,604+2.5%AddedHolders
Q1 20235,409,257$1.70B0.2%+26,538+0.5%AddedHolders
Q4 20225,382,719$1.55B0.2%+111,052+2.1%AddedHolders
Q3 20225,271,667$1.52B0.2%+737,183+16.3%AddedHolders
Q2 20224,534,484$1.28B0.2%+204,253+4.7%AddedHolders
Q1 20224,330,231$1.13B0.1%−25,989−0.6%ReducedHolders
Q4 20214,356,220$954.3M0.1%+53,868+1.3%AddedHolders
Q3 20214,302,352$778.3M0.1%+215,173+5.3%AddedHolders
Q2 20214,087,179$821.8M0.1%+145,993+3.7%AddedHolders
Q1 20213,941,186$844.6M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.